The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Unapproved Peptides Lack Safety Data, Regulatory Incentives Misaligned Matt Kaeberlein posted on the topic LinkedIn The FDA's Current Position on Peptides Explained Holt Law Therapeutic Goods Administration issues safety alert amid explosion of illegal peptide use ABC News